Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/EUCTR2005-001849-42-IT
EUCTR2005-001849-42-ITActive, not recruitingNot Applicable

A randomized, double blind, placebo controlled, parallel group study to determine the effect of BXL628 in patients with Chronic Non-Bacterial Prostatitis category III Chronic Pelvic Pain Syndrome, CP/CPPS

BIOXELL SPA0 sites120 target enrollmentStarted: December 20, 2005Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
120
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
Male

Inclusion Criteria

  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range
  • •F.1.3 Elderly (>=65 years) yes
  • •F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • Not provided

Investigators

Similar Trials

Active, not recruiting
Phase 1
Investigate the safety and efficacy of study drug ABX464 compared with placebo in patients with moderate to severe ulcerative colitis who have failed to other treatments.Moderate to Severe Ulcerative ColitisMedDRA version: 20.1Level: LLTClassification code 10066678Term: Acute ulcerative colitisSystem Organ Class: 100000004856
EUCTR2018-003558-26-HUABIVAX232
Active, not recruiting
Not Applicable
A randomized, double blind, placebo controlled, parallel-group study to determine the effect of BXL-628 in post-menopausal women with Overactive Bladder (OAB)
EUCTR2004-000609-23-ITBIOXELL SPA
Active, not recruiting
Not Applicable
A randomized, double blind, placebo controlled, parallel group trial for assessing the clinical benefit of Dronedarone 400mg BID on top of standard therapy in patients with permanent atrial fibrillation and additional risk factors - Permanent Atrial fibriLLAtion outcome Study using Dronedarone on top of standard therapy (PALLAS)MedDRA version: 12.1Level: LLTClassification code 10003658Term: Atrial fibrillationAtrial Fibrillation
EUCTR2010-019791-73-SKSanofi-aventis recherche & développement10,800
Completed
Not Applicable
A clinical study to find The safety and efficacy of Asafin in patients suffering from dyspepsia
CTRI/2018/01/011149Akay Flavours and Aromatics Private Limited60
Completed
Unknown
A study to evaluate the effect of Investigational Product on sleep quality and mood state in healthy adults
CTRI/2023/04/051364Vedic Lifesciences Pvt. Ltd175
A randomized, double blind, placebo... | Clinical Trial